Gerresheimer Group Takes Over Pharmaceutical Business of Glass Group Inc.

The Gerresheimer Group has taken over substantial parts of the business of Glass Group Inc. (GGI) in the USA.

The acquisition comprises both the container glass works in Millville, New Jersey, which specialises in pharmaceutical packaging with sales of around USD 55 million, and its 45.7% share in the Chinese specialty glass manufacturer Beijing Wheaton.The purchase "marks a quantum leap on the way to establishing our Group as a leading worldwide supplier of pharmaceutical packaging," says Dr. Axel Herberg, CEO and President of the Gerresheimer Group.

Glass Group Inc., a past competitor in the pharmaceutical glassware business in the USA, was forced to file for protection under Chapter 11 U.S. Bankruptcy Code at the end of February this year and thus became available for purchase. The price paid for the assets now acquired totalled around USD 20 million. Closing of the deal is expected in the coming week.

Through the acquisition Gerresheimer has expanded its already existing leadership position in wide areas of the USA market to cover the entire pharmaceutical glassware spectrum. In the past the Group had a strong lead in the field of tubular glass and pharmaceutical packaging produced from it, while in the field of container glass for pharmaceutics the Gerresheimer Group was in the past represented in the American market by only one plant. The plant in Millville now also makes the Group the leader in the USA for pharmaceutical container glass. Because of its high quality requirements, pharmaceutical glassware is generally regarded as a high-profile and particularly attractive market segment.

The new Millville plant has three furnaces, with 350 employees producing for example the highly specialised type I borosilicate glass which is processed to manufacture high-quality pharmaceutical packaging. In addition to Millville, Gerresheimer currently has five production plants in its American subsidiary Kimble Inc. plus a plant in Mexico.

The acquisition of shares in Beijing Wheaton in China is also of strategic importance for Gerresheimer. The investment offers "an excellent starting base to establish a foothold in the Asian market and rise to become an important player in the region," says Herberg.

Gerresheimer is one of the leading international manufacturers of high-quality packaging based on glass and plastic, particularly for the segments of pharmaceutics and cosmetics. The Group employs 5,100 people in 17 production plants in Europe and the USA and achieves sales of around EUR 560 million (pre-acquisition).

600450 Gerresheimer Group Takes Over Pharmaceutical Business of Glass Group Inc.

See more news about:

Others also read

Emirates Glass, a Dubai Investment subsidiary, has won a major contract to supply 140,000 square meters of its premium glass to the prestigious development on the Palm Jumeirah, reaffirming its already established reputation as the single most prominent company in the entire regional glass industry.The deal was announced during the company's participation in the prestigious Big 5 show, the largest annual venue for the entire Middle-East glass contracting industry.
Isra Vision Systems AG supplier of machine vision systems, has successfully improved its market position in display glass inspection with a major order totalling 1.8 Mio Euro.
Packagers such as the UK's Rexam and private equity firms are set to vie for pump-sprayer business Calmar, which France's Saint-Gobain (SGOB.
Jain Scientific Glass Works, manufacturers of glassware for laboratories, is importing glass as raw material from China, which was much cheaper than the local product and abundantly available.
The National Lime & Stone Co. will discontinue production of calcined lime early next month at its Carey plant, the company CEO announced Thursday.
The following stocks are moving in Japanese markets today. Prices are as of 12:55 p.m. at the Tokyo Stock Exchange. Stock symbols are in parentheses after company names.

Add new comment